Biotech IPO Shares Climb in Trading Debuts After Deals Upsized [Yahoo! Finance]
MBX Biosciences, Inc. (MBX)
Company Research
Source: Yahoo! Finance
(Bloomberg) -- A trio of biotech companies' shares rose in their first trading sessions after they each sold more shares in their respective initial public offerings than they had planned. Most Read from Bloomberg Bicara Therapeutics Inc. shares climbed 42% to $25.50 apiece as of 1:22 p.m. on Friday. The company had expanded its IPO to sell 17.5 million shares at $18 each, at the top of the price range, to raise $315 million, according to a statement. Shares of MBX Biosciences Inc. rose 43% to $22.87 each. Its enlarged first-time share sale raised $163 million, pricing 10.2 million shares at $16 each at the upper limit of the price range. Zenas BioPharma Inc. shares increased 4.4% to $17.75 each. The IPO raised $225 million, priced at $17 apiece, the middle of the marketed range. The offerings make this week the busiest for biotech and pharmaceuticals IPOs since July 2021, data compiled by Bloomberg show. They bring the volume this year raised by drug developers via IPOs to
Show less
Read more
Impact Snapshot
Event Time:
MBX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MBX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MBX alerts
High impacting MBX Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
MBX
News
- MBX Biosciences to Participate in Upcoming November Investor ConferencesGlobeNewswire
- MBX Biosciences, Inc. (NYSE: MBX) is now covered by analysts at Guggenheim. They set a "buy" rating and a $44.00 price target on the stock.MarketBeat
- MBX Biosciences, Inc. (NYSE: MBX) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $30.00 price target on the stock.MarketBeat
- MBX Biosciences, Inc. (NYSE: MBX) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $35.00 price target on the stock.MarketBeat
- MBX Biosciences, Inc. (NYSE: MBX) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $40.00 price target on the stock.MarketBeat
MBX
Sec Filings
- 9/23/24 - Form SC
- 9/23/24 - Form SC
- 9/23/24 - Form SC
- MBX's page on the SEC website